Survivin inhibits anti-growth effect of p53 activated by aurora B

Biochemical and Biophysical Research Communications

Volumn 336, Issue 4, 2005, Pages 1164-1171

  Jung, Ji Eun ^a   Kim, Tae Kyung ^a   Lee, Joong Seob ^a   Oh, Se Yeong ^a   Kwak, Sungwook ^a   Jin, Xun ^a   Sohn, Jin Young ^a   Song, Min Keun ^a   Sohn, Young Woo ^a   Lee, Soo Yeon ^a   Pian, Xumin ^a   Lee, Jang Bo ^b   Yong, Gu Chung ^b   Young, Ki Choi ^c   You, Seungkwon ^a   Kim, Hyunggee ^a  

^a Korea University   (South Korea)

^b Korea University College of Medicine   (South Korea)

^c Chungbuk National University College of Medicine   (South Korea)

Author keywords

Aurora B; Cell death; Cell growth; Glioblastoma; p53; Survivin

Indexed keywords

AURORA B KINASE; BETA GALACTOSIDASE; PROTEIN; PROTEIN P53; SURVIVIN; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ANCHORAGE INDEPENDENT GROWTH; APOPTOSIS; ARTICLE; ASTROCYTE; CARCINOGENESIS; CELL AGING; CELL GROWTH; CELL PROLIFERATION; CENTROSOME; CHROMOSOME; CONTROLLED STUDY; DRUG SENSITIVITY; ENZYME ACTIVITY; GENETIC TRANSDUCTION; GLIOBLASTOMA; GROWTH INHIBITION; HUMAN; HUMAN CELL; MOUSE; MULTIGENE FAMILY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR; TUMOR CELL LINE;

ANIMALS; APOPTOSIS; ASTROCYTES; BRAIN NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; CENTROSOME; CONTACT INHIBITION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; ENZYME ACTIVATION; GENES, REPORTER; GLIOBLASTOMA; HUMANS; MICE; MICROTUBULE-ASSOCIATED PROTEINS; NEOPLASM PROTEINS; NEOPLASMS; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; TUMOR SUPPRESSOR PROTEIN P53;

EID: 25644436964     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2005.08.235     Document Type: Article

References (32)

1. M. Classon, and E. Harlow The retinoblastoma tumour suppressor in development and cancer Nat. Rev. Cancer 2 2002 910 917
2. K.H. Vousden, and X. Lu Live or let die: the cell's response to p53 Nat. Rev. Cancer 2 2002 594 604
3. P. Chene Inhibiting the p53-MDM2 interaction: an important target for cancer therapy Nat. Rev. Cancer 3 2003 102 109
4. W.S. el-Deiry, T. Tokino, V.E. Velculescu, D.B. Levy, R. Parsons, J.M. Trent, D. Lin, W.E. Mercer, K.W. Kinzler, and B. Vogelstein WAF1, a potential mediator of p53 tumor suppression Cell 75 1993 817 825
5. T. Miyashita, and J.C. Reed Tumor suppressor p53 is a direct transcriptional activator of the human bax gene Cell 80 1995 293 299
6. E. Oda, R. Ohki, H. Murasawa, J. Nemoto, T. Shibue, T. Yamashita, T. Tokino, T. Taniguchi, and N. Tanaka Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis Science 288 2000 1053 1058
7. F.H. Igney, and P.H. Krammer Death and anti-death: tumour resistance to apoptosis Nat. Rev. Cancer 2 2002 277 288
8. S. Cory, and J.M. Adams The Bcl2 family: regulators of the cellular life-or-death switch Nat. Rev. Cancer 2 2002 647 656
9. J.C. Reed The survivin saga goes in vivo J. Clin. Invest 108 2001 965 969
10. C.G. Ferreira, P. van derValk, S.W. Span, J.M. Jonker, P.E. Postmus, F.A. Kruyt, and G. Giaccone Assessment of IAP (inhibitor of apoptosis) proteins as predictors of response to chemotherapy in advanced non-small-cell lung cancer patients Ann. Oncol 12 2001 799 805
11. H.S. Hofmann, A. Simm, A. Hammer, R.E. Silber, and B. Bartling Expression of inhibitors of apoptosis (IAP) proteins in non-small cell human lung cancer J. Cancer Res. Clin. Oncol 128 2002 554 560
12. I. Tamm, S.M. Kornblau, H. Segall, S. Krajewski, K. Welsh, S. Kitada, D.A. Scudiero, G. Tudor, Y.H. Qui, A. Monks, M. Andreeff, and J.C. Reed Expression and prognostic significance of IAP-family genes in human cancers and myeloid leukemias Clin. Cancer Res. 6 2000 1796 1803
13. F. Li, G. Ambrosini, E.Y. Chu, J. Plescia, S. Tognin, P.C. Marchisio, and D.C. Altieri Control of apoptosis and mitotic spindle checkpoint by survivin Nature 396 1998 580 584
14. D.C. Altieri Validating survivin as a cancer therapeutic target Nat. Rev. Cancer 3 2003 46 54
15. R.R. Adams, H. Maiato, W.C. Earnshaw, and M. Carmena Essential roles of Drosophila inner centromere protein (INCENP) and aurora B in histone H3 phosphorylation, metaphase chromosome alignment, kinetochore disjunction, and chromosome segregation J. Cell Biol. 153 2001 865 880
16. R.R. Adams, M. Carmena, and W.C. Earnshaw Chromosomal passengers and the (aurora) ABCs of mitosis Trends Cell Biol. 11 2001 49 54
17. S. Kaitna, M. Mendoza, V. Jantsch-Plunger, and M. Glotzer Incenp and an aurora-like kinase form a complex essential for chromosome segregation and efficient completion of cytokinesis Curr. Biol 10 2000 1172 1181
18. Y. Wei, L. Yu, J. Bowen, M.A. Gorovsky, and C.D. Allis Phosphorylation of histone H3 is required for proper chromosome condensation and segregation Cell 97 1999 99 109
19. J.Y. Hsu, Z.W. Sun, X. Li, M. Reuben, K. Tatchell, D.K. Bishop, J.M. Grushcow, C.J. Brame, J.A. Caldwell, D.F. Hunt, R. Lin, M.M. Smith, and C.D. Allis Mitotic phosphorylation of histone H3 is governed by Ipl1/aurora kinase and Glc7/PP1 phosphatase in budding yeast and nematodes Cell 102 2000 279 291
20. R. Giet, and D.M. Glover Drosophila aurora B kinase is required for histone H3 phosphorylation and condensin recruitment during chromosome condensation and to organize the central spindle during cytokinesis J. Cell Biol. 152 2001 669 682
21. C. Crosio, G.M. Fimia, R. Loury, M. Kimura, Y. Okano, H. Zhou, S. Sen, C.D. Allis, and P. Sassone-Corsi Mitotic phosphorylation of histone H3: spatio-temporal regulation by mammalian Aurora kinases Mol. Cell. Biol. 22 2002 874 885
22. H. Goto, Y. Yasui, E.A. Nigg, and M. Inagaki Aurora-B phosphorylates Histone H3 at serine28 with regard to the mitotic chromosome condensation Genes Cell 7 2002 11 17
23. T. Ota, S. Suto, H. Katayama, Z.B. Han, F. Suzuki, M. Maeda, M. Tanino, Y. Terada, and M. Tatsuka Increased mitotic phosphorylation of histone H3 attributable to AIM-1/Aurora-B overexpression contributes to chromosome number instability Cancer Res. 62 2002 5168 5177
24. D. Hanahan, and R.A. Weinberg The hallmarks of cancer Cell 100 2000 57 70
25. G.P. Dimri, X. Lee, G. Basile, M. Acosta, G. Scott, C. Roskelley, E.E. Medrano, M. Linskens, I. Rubelj, O. Pereira-Smith, M. Peacoche, and J. Campisi A biomarker that identifies senescent human cells in culture and in aging skin in vivo Proc. Natl. Acad Sci. USA 92 1995 9363 9367
26. M.A. Bolton, W. Lan, S.E. Powers, M.L. McCleland, J. Kuang, and P.T. Stukenberg Aurora B kinase exists in a complex with survivin and INCENP and its kinase activity is stimulated by survivin binding and phosphorylation Mol. Biol. Cell 13 2002 3064 3077
27. N. Ishii, D. Maier, A. Merlo, M. Tada, Y. Sawamura, A.C. Diserens, and E.G. Van Meir Frequent co-alterations of TP53, p16/CDKN2A, p14ARF, PTEN tumor suppressor genes in human glioma cell lines Brain Pathol. 9 1999 469 479
28. T. Bowman, H. Symonds, L. Gu, C. Yin, M. Oren, and T. Van Dyke Tissue-specific inactivation of p53 tumor suppression in the mouse Genes Dev. 10 1996 826 835
29. C.D. Lu, D.C. Altieri, and N. Tanigawa Expression of a novel antiapoptosis gene, survivin, correlated with tumor cell apoptosis and p53 accumulation in gastric carcinomas Cancer Res. 58 1998 1808 1812
30. D. Grossman, P.J. Kim, O.P. Blanc-Brude, D.E. Brash, S. Tognin, P.C. Marchisio, and D.C. Altieri Transgenic expression of survivin in keratinocytes counteracts UVB-induced apoptosis and cooperates with loss of p53 J. Clin. Invest. 108 2001 991 999
31. A. Chakravarti, E. Noll, P.M. Black, D.F. Finkelstein, D.M. Finkelstein, N.J. Dyson, and J.S. Loeffler Quantitatively determined survivin expression levels are of prognostic value in human gliomas J. Clin. Oncol. 20 2002 1063 1068
32. M. Tatsuka, H. Katayama, T. Ota, T. Tanaka, S. Odashima, F. Suzuki, and Y. Terada Multinuclearity and increased ploidy caused by overexpression of the aurora- and Ipl1-like midbody-associated protein mitotic kinase in human cancer cells Cancer Res. 58 1998 4811 4816